Status:
COMPLETED
Efficacy of Platelet Rich Plasma for Treatment of Muscle Rupture With Haematoma
Lead Sponsor:
Institut de Terapia Regenerativa Tissular
Collaborating Sponsors:
Asociacion Colaboracion Cochrane Iberoamericana
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Conditions:
Muscle Injuries
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This is a multicenter, simple blind, masking of outcomes assessors, parallel, randomised clinical trial in patient with muscle rupture and with hematoma production. The main hypothesis is that infiltr...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Adults over 18 years
- Lesion with haematoma at the Gastrocnemius muscle or the lower portion of the rectus femoral muscle
- Acceptance to participate at the clinical trial
- Not indicated the surgical treatment of the muscle injury
- Exclusion criteria
- Patients who do not meet the inclusion criteria
- History of bleeding disorders
- Inability to follow-up the patient
- The use of corticosteroids, acetylsalicylic acid(Aspirin ®) and nonsteroidal antiinflammatory drugs during the study
Exclusion
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT01440725
Start Date
October 1 2009
End Date
December 1 2012
Last Update
January 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Cochrane Iberoamericano
Barcelona, Barcelona, Spain, 08041